We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App





Researchers Achieve Significant Breakthrough in Extracting Key Antibodies to Neutralize Coronavirus

By HospiMedica International staff writers
Posted on 06 May 2020
In a groundbreaking scientific development, scientists from the Israel Institute for Biological Research {(IIBR) Ness-Ziona, Israel} have identified an antibody that neutralizes the coronavirus, SARS-CoV-2.

The institute had recently begun testing a COVID-19 vaccine prototype on rodents and is also undertaking plasma collection from people who have recovered from COVID-9 infection.

In IIBR’s latest scientific breakthrough, the identified antibody is monoclonal, new and refined, and contains an exceptionally low proportion of harmful proteins. More...
The institute has also demonstrated the ability of the antibody to neutralize the novel coronavirus and has specifically tested it on the aggressive coronavirus.

The IIBR has now begun the process of patenting its antibody and securing a contract for its commercial development. It expects to complete full development and secure approvals for its coronavirus vaccine in early 2021. The institute also plans to open Israel's first vaccine production facility in partnership with one of two prospective international pharmaceutical companies, one from India and the other from the US. The facility will manufacture tens of millions of vaccine units of various types to ensure self-sufficiency for Israel during regular routine vaccinations as well as in case of a pandemic.

Related Links:
Israel Institute for Biological Research


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
OR Table Accessory
Angular Accessory Rail
Isolation Stretcher
IS 736
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.